Skip to content

Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.

Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07306975
Enrollment
80
Registered
2025-12-29
Start date
2025-12-10
Completion date
2027-12-01
Last updated
2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Patients Referred to do PET/CT Study

Keywords

SUV measurements , correction, PET/CT

Brief summary

-To measure SUVs by using different correction methods in oncological PET/CT imaging.

Detailed description

-To compare between SUV measurements in the tumor and liver using different standardizing parameters such as: body weight, lean body mass and body surface area.

Interventions

* Patients will fast for at least 4 hrs before imaging with blood glucose level (\<200 mg/dl) before intravenous administration of F18-FDG. * Imaging will be performed approximately 45 to 60 min after 18F-FDG injection, an imaging field of view from the base of skull to mid-thighs with the arms above the head whenever possible is used or otherwise the arms are positioned beside the body.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Cancer patients (\> 18 years old) referred to nuclear medicine unit to do F18-FDG PET/CT study.

Exclusion criteria

* Patients \< 18 years old. * Patients with increased FDG uptake on tissue associated with non-malignant causes such as diffuse bone marrow FDG uptake or inflammatory. * Patients with extensive metastasis.

Design outcomes

Primary

MeasureTime frameDescription
-To measure SUVs by using different correction methods in oncological PET/CT imaging.1/12/2025 to 1/10/2027-To compare between SUV measurements in the tumor and liver using different standardizing parameters such as: body weight, lean body mass and body surface area.

Secondary

MeasureTime frameDescription
To determine if SUVbsa is more accurate than SUVbw in obese patients.1/12/2025 to 1/10/2027-To determine if ''normalization of FDG uptake for the body surface area'' (SUVbsa) is independent of the patient's body size and is more reliable than SUVbw.

Contacts

Primary ContactHebatAllah Ahmed AbdelRaoof Askar, Assistant Professor, doctor
hebaaskar@aun.edu.eg+2001003040898
Backup ContactAya Kamel Hamed Ahmed, Resident doctor
aya.17289799@med.aun.edu.eg+2001097763423

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026